Book traversal links for 6.3.1 PLHIV
Currently, there are no specific changes in using longer regimens in PLHIV. However, there can be cumulative risk factors for clinical complications, toxicities and drug–drug interactions (Web Annex 1 and Web Annex 2); hence, these patients may need close follow-up and support.